EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

More micrometastases, more recurrence? The role of qPCR of PSA mRNA in lymph nodes during prostatectomy

Johannes Troidl, Alexander Fehr, Burkhard Jandrig, Jens Köllermann, Anke Lux, Daniel Baumunk, Melis Gür, Uwe-B Liehr, Markus Porsch, Johann J Wendler, Simon Blaschke, Martin Schostak

World Journal of Urology · 2025

DOI: 10.1007/s00345-024-05414-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2025. Verfasst von Johannes Troidl und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Urooncology, Robot-assisted and Focal Therapy, University Hospital Magdeburg, Otto-von Guericke University Magdeburg, Leipzige…. Hauptthemen laut MEDLINE: Prostatectomy, Prostatic Neoplasms, Prostate-Specific Antigen, RNA, Messenger. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Magdeburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Radical prostatectomy is a standard treatment for prostate cancer, yet about 30% of patients experience rising biochemical markers within a decade post-surgery. Pelvic lymph node sampling during prostatectomy assesses potential lymph node metastases, but standard histological assessments, which typically examine only 2–3 tissue sections, often miss occult metastases. This study assesses the effectiveness of qPCR in detecting PSA coding KLK3 mRNA for identifying lymph node metastases post-prostatectomy and explores the correlation between PSA-mRNA and biochemical recurrence. Methods A cohort of 157 patients who underwent radical prostatectomy with lymphadenectomy were examine. On average, 24.7 lymph nodes were removed per patient. Among them, 108 patients reached PSA value below 0.1 ng/ml without receiving additional therapy, and 106 were followed up over a duration of 5.4 years. This subgroup is of particular interest because it allows for the investigation of the correlation between the occurrence of PSA-mRNA in lymph nodes and later biochemical recurrence. Key findings and limitations qPCR of PSA-mRNA identified 47 out of 108 positive cases (43.5%), while histopathological examination only detected 16 out of 108 cases (14.8%). From the followed-up subgroup 37 out of 106 patients (34.9%) experienced biochemical recurrence. It is noteworthy that qPCR yields more positive findings, regardless of the presence of biochemical recurrence. Conclusion and clinical implications The study findings illustrate that qPCR consistently outperforms conventional histology in detecting lymph node metastases, regardless of biochemical recurrence. The hypothesis that qPCR is better at predicting later biochemical recurrence than conventional histology has not been confirmed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyProstatic NeoplasmsProstate-Specific AntigenRNA, MessengerNeoplasm Recurrence, LocalLymphatic MetastasisNeoplasm MicrometastasisLymph NodesHumansMaleAgedMiddle AgedLymph Node ExcisionKallikreinsReal-Time Polymerase Chain Reaction

Stichwörter der Autor:innen

Biochemical recurrenceLymph node metastasesProstate cancerQPCRRadical prostatectomy

Substanzen

Prostate-Specific AntigenRNA, MessengerKallikreinsKLK3 protein, human

Autor:innen und Institutionen

  • Department of Urology, Urooncology, Robot-assisted and Focal Therapy, University Hospital Magdeburg, Otto-von Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany. johannes.troidl@st.ovgu.de.
  • Department of Urology, Urooncology, Robot-assisted and Focal Therapy, University Hospital Magdeburg, Otto-von Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.
  • Senckenbergische Institute für Pathology & Genetics, Frankfurt/Main, Germany.
  • Institute of Biometry and Medical Informatics, University Hospital, Otto-Von Guericke University, Magdeburg, Germany.
  • Praxis Baumunk & Baumunk, Backnang, Germany.
  • Urologen am Hassel, Magdeburg, Germany.

Förderung

  • Universitätsklinikum Magdeburg

Zitieren

APA

Troidl, J., Fehr, A., Jandrig, B., Köllermann, J., Lux, A., Baumunk, D., Gür, M., Liehr, U. B., Porsch, M., Wendler, J. J., Blaschke, S., & Schostak, M. (2025). More micrometastases, more recurrence? The role of qPCR of PSA mRNA in lymph nodes during prostatectomy. World Journal of Urology. https://doi.org/10.1007/s00345-024-05414-2

Vancouver

Troidl J, Fehr A, Jandrig B, Köllermann J, Lux A, Baumunk D, et al. More micrometastases, more recurrence? The role of qPCR of PSA mRNA in lymph nodes during prostatectomy. World Journal of Urology. 2025. doi:10.1007/s00345-024-05414-2

BibTeX
@article{Troidl2025,
  author = {Troidl, Johannes and Fehr, Alexander and Jandrig, Burkhard and Köllermann, Jens and Lux, Anke and Baumunk, Daniel and Gür, Melis and Liehr, Uwe-B and Porsch, Markus and Wendler, Johann J and Blaschke, Simon and Schostak, Martin},
  title = {More micrometastases, more recurrence? The role of qPCR of PSA mRNA in lymph nodes during prostatectomy},
  journal = {World Journal of Urology},
  year = {2025},
  doi = {10.1007/s00345-024-05414-2}
}
Kostenlos starten →